Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of Fuke Tiaojing Tablet and its preparation process

A gynecological menstrual adjustment and preparation technology technology, applied in the field of medicine, can solve the problems of unsatisfactory bioavailability, drug stability, low bioavailability of active ingredients, unsatisfactory curative effect, etc., and achieves improved compliance, suitable hardness, fast-acting effect

Active Publication Date: 2021-04-09
JIANGXI GUOYAO PHARMA LLC
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the reasons of prescription and process, the curative effect of Fuke Tiaojing Tablets on the market is not ideal, and the preparation is prepared by traditional technology, which has the disadvantages of slow disintegration and low curative effect
The bioavailability and drug stability of traditional dosage forms are not ideal, especially the problem of low bioavailability of active ingredients needs to be solved urgently; in view of these situations, improving the process or composition of the prescription has become a matter that people urgently need to solve

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of Fuke Tiaojing Tablet and its preparation process
  • A kind of Fuke Tiaojing Tablet and its preparation process

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0028] The invention also provides a preparation process of Fuke Tiaomeng Tablets, in which part of the medicinal components is superfinely pulverized to obtain ultrafine powder and sterilized for use; part of the medicinal components is extracted by boiling, high-speed centrifugation, and concentrated to prepare clear ointment and thick ointment. The clear paste is used as a component of the composite binder, the thick paste is mixed with the ultrafine powder obtained by crushing, and microcrystalline cellulose, the composite binder is added to make granules, the granules are sized, mixed with other auxiliary materials, compressed into tablets, and coated to obtain the product .

[0029] In a preferred embodiment, the supplementary materials for preparing Menstruation Tablets also include 1-5 parts of Tween-80; the sterilization condition of the ultra-fine powder obtained by ultrafine pulverization is 105-110°C for 25-30min; high-speed centrifuge The rotation speed is 12000-1...

Embodiment 1

[0055] The raw material of Fuke Tiaojing Tablets is made of medicinal compound and auxiliary materials. The medicinal compound is composed of 23 parts of bran-fried Atractylodes Rhizome, 32 parts of vinegar Yanhusuo, 400 parts of vinegar cyperus, 144 parts of angelica, 11 parts of licorice, and 16 parts of Chuanxiong. 12 parts of white peony root, 48 parts of Rehmannia glutinosa, 12 parts of red peony root, 8 parts of safflower, 8 parts of motherwort, 8 parts of ginseng, 80 parts of jujube, 8 parts of lotus seeds, 8 parts of yam, 10 parts of Panax notoginseng, 5 parts of medlar The excipients are 20 parts of microcrystalline cellulose, 45 parts of composite binder, 40 parts of croscarmellose sodium starch and 15 parts of magnesium stearate.

[0056] The ratio of the clear paste, hydroxypropyl cellulose and 95% ethanol in the composite adhesive is 1g: 0.3g: 0.5mL.

[0057] The preparation process steps of Tiaojing Tablet are as follows:

[0058] (1) Grinding the aforementioned...

Embodiment 2

[0066] The raw material of Fuke Tiaojing Tablets is made of medicinal compound and auxiliary materials. The medicinal compound is composed of 20 parts of bran-fried Atractylodes Rhizome, 30 parts of vinegar Corydalis Corydalis, 380 parts of Vinegar Cyperus, 140 parts of Angelica sinensis, 10 parts of Licorice Root, and 10 parts of Rhizoma Chuanxiong. 10 parts of white peony root, 40 parts of Rehmannia glutinosa, 10 parts of red peony root, 15 parts of safflower, 10 parts of motherwort, 15 parts of ginseng, 85 parts of jujube, 15 parts of lotus seeds, 10 parts of yam, 15 parts of Panax notoginseng, 7 parts of medlar parts, auxiliary materials are 30 parts of microcrystalline cellulose, 60 parts of composite binder, 50 parts of croscarmellose sodium and 30 parts of micropowder silica gel.

[0067] The ratio of the clear paste, hydroxypropyl cellulose and 95% ethanol in the composite adhesive is 1g: 0.4g: 0.6mL.

[0068] The preparation process steps of Tiaojing Tablet are as fol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The present invention relates to a Fuke Tiaojing Tablet and its preparation process. The Tiaojing Tablet is composed of bran-fried Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizome, Vinegar Corydalis Corydalis, Vinegar Cyperus, Angelica, Licorice, Chuanxiong, Radix Paeoniae Alba, Rehmannia glutinosa, Radix Paeoniae Rubra, Safflower, Motherwort, Ginseng , jujube, lotus seeds, yam, notoginseng, wolfberry, microcrystalline cellulose, composite binder, disintegrant and lubricant, wherein the composite binder is made of clear paste with a specific gravity of 1.05, hydroxypropyl fiber element and 95% ethanol by volume. The preparation process of Tiaojing Tablets is as follows: some medicinal components are superfinely pulverized to obtain ultra-fine powder, and then sterilized; some medicinal components are extracted by boiling, high-speed centrifugation, and concentrated to prepare clear ointment and thick ointment, and the clear ointment is used as a composite adhesive The composition of the agent is mixed with thick paste, ultrafine powder and microcrystalline cellulose, added with composite binder to make granules, granulated, mixed with other auxiliary materials, compressed into tablets, and coated to obtain the product. The menstrual regulating tablet prepared by the invention is smooth and fine, uniform in thickness, fast in disintegration, small in dosage and good in curative effect.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a gynecological menstrual regulating tablet and a preparation process thereof. Background technique [0002] Irregular menstruation is a common gynecological disease, manifested as abnormal menstrual cycle or bleeding, or abdominal pain and systemic symptoms before or during menstruation. The cause may be organic disease or dysfunction, blood disease, hypertension, liver disease, endocrine disease, miscarriage, ectopic pregnancy, hydatidiform mole, reproductive tract infection, ovarian tumor, uterine fibroids, etc. can all cause menstrual disorders. Irregular menstruation brings great pain to women. It is easy to produce a large number of acne spots on women's faces, easily cause gynecological inflammation, and even lead to infertility, which seriously threatens women's health. In order to achieve the purpose of prevention and treatment, many inventors and pharmaceu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8945A61K9/28A61K9/30A61P15/00A61P29/00
CPCA61K9/0002A61K9/28A61K9/282A61K36/232A61K36/236A61K36/258A61K36/284A61K36/286A61K36/484A61K36/533A61K36/62A61K36/65A61K36/66A61K36/71A61K36/725A61K36/804A61K36/815A61K36/8905A61K36/8945A61K47/02A61K47/32A61K47/34A61K47/36A61K47/38A61K2236/331A61K2236/39A61K2236/51A61K2236/53A61P15/00A61P29/00A61K2300/00
Inventor 关媛媛万义斌葛友群左飞鸿袁任春周莉萍
Owner JIANGXI GUOYAO PHARMA LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products